Eli Lilly/LLY

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Eli Lilly

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.

Ticker

LLY

Sector

Healthcare

Trading on

NYSE

Industry

Pharmaceuticals

Headquarters

Indianapolis, United States

Employees

43,000

Eli Lilly Metrics

BasicAdvanced
$796B
Market cap
130.17
P/E ratio
$6.79
EPS
0.36
Beta
$4.69
Dividend rate
0.53%
Dividend yield
$796B
0.36
$4.69
1.354
0.674
191.352
204.278
68.77%
20.98%
12.60%
50.75%
130.17
22.13
62.14
717.05
-347.18
0.53%
29.76%
7.97%
12.13%
0.55%
15.17%

What the Analysts think about Eli Lilly

Analyst Ratings

Majority rating from 29 analysts.
Buy

Eli Lilly Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
25.58% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$8.8B
-6.26%
Net income
$2.2B
2.43%
Profit margin
25.58%
9.27%

Eli Lilly Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 4.95%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$2.11
$0.10
$2.49
$2.58
-
Expected
$1.98
-$0.13
$2.22
$2.46
$2.75
Surprise
6.60%
-174.32%
12.22%
4.95%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market openNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Eli Lilly stock?

Eli Lilly (LLY) has a market cap of $796B as of June 24, 2024.

What is the P/E ratio for Eli Lilly stock?

The price to earnings (P/E) ratio for Eli Lilly (LLY) stock is 130.17 as of June 24, 2024.

Does Eli Lilly stock pay dividends?

Yes, the Eli Lilly (LLY) stock pays dividends to shareholders. As of June 24, 2024, the dividend rate is $4.69 and the yield is 0.53%. Eli Lilly has a payout ratio of 68.77% on a trailing twelve-month basis.

When is the next Eli Lilly dividend payment date?

The next Eli Lilly (LLY) dividend payment date is unconfirmed.

What is the beta indicator for Eli Lilly?

Eli Lilly (LLY) has a beta rating of 0.36. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

What is the Eli Lilly stock price target?

The target price for Eli Lilly (LLY) stock is $861.03, which is NaN% below the current price of $. This is an average based on projections from 25 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Eli Lilly stock

Buy or sell Eli Lilly stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing